JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Home・Akciju saraksts・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Slēgts

2.25 10.29

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.21

Max

2.27

Galvenie mērījumi
By Trading Economics
Ienākumi	1.1M -16M
Pārdošana	2.8M 50M
Peļņas marža	-32.437
Darbinieki	477
EBITDA	1.3M -12M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+132.3% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 26. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-272M 144M
Iepriekšējā atvēršanas cena	-8.04
Iepriekšējā slēgšanas cena	2.25

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

7.16 / 7.65 Atbalsts un pretestība

Treace Medical Concepts Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 8. febr. 23:57 UTC

Tirgus saruna

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

2026. g. 8. febr. 23:47 UTC

Tirgus saruna

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

2026. g. 8. febr. 23:43 UTC

Tirgus saruna

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

2026. g. 8. febr. 23:34 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 8. febr. 23:34 UTC

Tirgus saruna

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

2026. g. 8. febr. 23:26 UTC

Tirgus saruna

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

2026. g. 8. febr. 22:55 UTC

Peļņas

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

2026. g. 8. febr. 21:43 UTC

Tirgus saruna

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

2026. g. 8. febr. 21:16 UTC

Tirgus saruna

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

2026. g. 8. febr. 21:15 UTC

Tirgus saruna

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

2026. g. 7. febr. 09:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 7. febr. 09:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 7. febr. 05:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 7. febr. 02:46 UTC

Iegādes, apvienošanās, pārņemšana

Big Money, High Anxiety -- Barrons.com

2026. g. 6. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 6. febr. 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 6. febr. 21:40 UTC

Iegādes, apvienošanās, pārņemšana

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

2026. g. 6. febr. 21:22 UTC

Tirgus saruna

Mexico's Inflation Seen Accelerating in January -- Market Talk

2026. g. 6. febr. 21:17 UTC

Peļņas

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

2026. g. 6. febr. 21:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 6. febr. 21:14 UTC

Iegādes, apvienošanās, pārņemšana

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

2026. g. 6. febr. 21:13 UTC

Peļņas

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

2026. g. 6. febr. 21:13 UTC

Peļņas

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

2026. g. 6. febr. 21:04 UTC

Tirgus saruna

Gold Closes Out Volatile Week on Higher Note -- Market Talk

2026. g. 6. febr. 20:34 UTC

Peļņas

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Treace Medical Concepts Inc Prognoze

Cenas mērķis

By TipRanks

132.3% augšup

Prognoze 12 mēnešiem

Vidējais 5.25 USD 132.3%

Augstākais 7.5 USD

Zemākais 3 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.16 / 7.65Atbalsts un pretestība

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.